Hansa Biopharma AB (HNSA) — Free Cash Flow Generation Index
Latest as of September 2020:
1.00x
Hansa Biopharma AB (HNSA) has a Free Cash Flow Generation Index of 1.00x as of September 2020. Free cash flow of Skr4.83 Million represents 1% of operating cash flow (Skr4.83 Million). Explore HNSA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
Skr4.83 Million
SEK
Operating Cash Flow
Skr4.83 Million
SEK
Capital Expenditures
Skr683.00K
SEK
Annual Free Cash Flow Generation for Hansa Biopharma AB (None–None)
Year-by-year Free Cash Flow Generation Index for Hansa Biopharma AB. Check total reinvestment intensity of Hansa Biopharma AB to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).